<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu Q</submitter><funding>NEI NIH HHS</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>NIDA NIH HHS</funding><funding>Brain Research Foundation</funding><funding>NIMH NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIH</funding><funding>NIGMS NIH HHS</funding><pagination>863-875.e6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6524650</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>101(5)</volume><pubmed_abstract>Regulated secretion is critical for diverse biological processes ranging from immune and endocrine signaling to synaptic transmission. Botulinum and tetanus neurotoxins, which specifically proteolyze vesicle fusion proteins involved in regulated secretion, have been widely used as experimental tools to block these processes. Genetic expression of these toxins in the nervous system has been a powerful approach for disrupting neurotransmitter release within defined circuitry, but their current utility in the brain and elsewhere remains limited by lack of spatial and temporal control. Here we engineered botulinum neurotoxin B so that it can be activated with blue light. We demonstrate the utility of this approach for inducibly disrupting excitatory neurotransmission, providing a first-in-class optogenetic tool for persistent, light-triggered synaptic inhibition. In addition to blocking neurotransmitter release, this approach will have broad utility for conditionally disrupting regulated secretion of diverse bioactive molecules, including neuropeptides, neuromodulators, hormones, and immune molecules. VIDEO ABSTRACT.</pubmed_abstract><journal>Neuron</journal><pubmed_title>A Photoactivatable Botulinum Neurotoxin for Inducible Control of Neurotransmission.</pubmed_title><pmcid>PMC6524650</pmcid><funding_grant_id>R01 GM100225</funding_grant_id><funding_grant_id>GO1011/12-1</funding_grant_id><funding_grant_id>R01NS107554</funding_grant_id><funding_grant_id>1UF1NS107710</funding_grant_id><funding_grant_id>CRC1080-B2</funding_grant_id><funding_grant_id>R01DA35821</funding_grant_id><funding_grant_id>R01 NS095809</funding_grant_id><funding_grant_id>T32 GM007635</funding_grant_id><funding_grant_id>R01NS082271</funding_grant_id><funding_grant_id>R01 NS082271</funding_grant_id><funding_grant_id>R01 NS107554</funding_grant_id><funding_grant_id>R21EY026363</funding_grant_id><funding_grant_id>SPP1926 – Next Generation Optogenetics</funding_grant_id><funding_grant_id>R21 EY026363</funding_grant_id><funding_grant_id>R01NS95809</funding_grant_id><funding_grant_id>R01 DA035821</funding_grant_id><funding_grant_id>R01GM100225</funding_grant_id><funding_grant_id>R00 MH103531</funding_grant_id><funding_grant_id>R00MH103531</funding_grant_id><funding_grant_id>UF1 NS107710</funding_grant_id><pubmed_authors>Ford CP</pubmed_authors><pubmed_authors>Grybko MJ</pubmed_authors><pubmed_authors>Boxer EE</pubmed_authors><pubmed_authors>Sinnen BL</pubmed_authors><pubmed_authors>Schneider MW</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Aoto J</pubmed_authors><pubmed_authors>Tucker CL</pubmed_authors><pubmed_authors>Wysoczynski CL</pubmed_authors><pubmed_authors>Gibson ES</pubmed_authors><pubmed_authors>Gottschalk A</pubmed_authors><pubmed_authors>Buchta WC</pubmed_authors><pubmed_authors>Kennedy MJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Photoactivatable Botulinum Neurotoxin for Inducible Control of Neurotransmission.</name><description>Regulated secretion is critical for diverse biological processes ranging from immune and endocrine signaling to synaptic transmission. Botulinum and tetanus neurotoxins, which specifically proteolyze vesicle fusion proteins involved in regulated secretion, have been widely used as experimental tools to block these processes. Genetic expression of these toxins in the nervous system has been a powerful approach for disrupting neurotransmitter release within defined circuitry, but their current utility in the brain and elsewhere remains limited by lack of spatial and temporal control. Here we engineered botulinum neurotoxin B so that it can be activated with blue light. We demonstrate the utility of this approach for inducibly disrupting excitatory neurotransmission, providing a first-in-class optogenetic tool for persistent, light-triggered synaptic inhibition. In addition to blocking neurotransmitter release, this approach will have broad utility for conditionally disrupting regulated secretion of diverse bioactive molecules, including neuropeptides, neuromodulators, hormones, and immune molecules. VIDEO ABSTRACT.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Mar</publication><modification>2024-11-20T23:55:19.16Z</modification><creation>2020-10-29T12:17:30Z</creation></dates><accession>S-EPMC6524650</accession><cross_references><pubmed>30704911</pubmed><doi>10.1016/j.neuron.2019.01.002</doi></cross_references></HashMap>